3.4 COVID-19 related complications
acute renal injury, liver dysfunction, Disseminated intravascular coagulation
COMPLICATIONS, DISSEMINATED INTRAVASCULAR COAGULATION
The median [IQR] duration of hospital stay was 6 [4, 9] days, which was similar between groups (p = 0.45). A total of 12 patients were admitted to the ICU or high dependency unit (Aggrenox: 5 vs control: 7, p = 0.88), which lasted a median of 2 [1, 5] days. All patients required some form of oxygen therapy, which lasted a median of 5 [4, 9] days and was similarly represented between study groups (p = 0.82). The oxygen therapy mostly consisted of non-invasive ventilation in 26.5% of patients (Aggrenox: 12 vs control: 14, p = 0.15) compared to invasive ventilation in 9.2% of patients (Aggrenox: 4 vs control: 5, p = 1.00). All other patients (64.3%) received oxygen therapy with nasal cannula only. The maximum oxygen flow volume received in patients was statistically similar between study groups (p = 0.36).The most common complications included liver dysfunction among 21.4% of patients (Aggrenox: 9 vs control: 12, p = 0.54) and acute renal injury among 14.3% of patients (Aggrenox: 5 vs control: 9, p = 0.71). Disseminated intravascular coagulation occurred in only 3 patients, all of which were in the control group (6.1%). Additional antibiotics were required in a total of 17.3% of patients (Aggrenox: 5 vs control: 12, p = 0.14). These data are presented in S4 Table in 